See on Scoop.it – Prostate Cancer: Psycho-Social Aspects to Disease Pathway Management
Long-term Data Show Ra-223 Safe in Advanced Prostate Cancer Medscape In an updated report of the ALSYMPCA trial, no major safety issues were identified within ~1.5 years after the end of treatment in a population of men with castration-resistant…
Terry Hill‘s insight:
This is good news!
See on login.medscape.com
